Market Overview

Notable Call Options Activity in Immunomedics


Shares of Immunomedics (NASDAQ: IMMU) are lower on the session by 0.63%, currently trading at $3.17. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.

Options traders are focusing on calls today. The strike seeing the heaviest volume is the January 2012 $6.00 call, which has traded 1,000 times on open interest of 4,466 contracts.

Calls are outpacing puts today by 1,000 to 1.

Immunomedics, Inc. is a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Posted-In: Options Markets


Related Articles (IMMU)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→